Network for implementing multiomics approaches in atherosclerotic cardiovascular disease prevention and research (AtheroNET)

Grunddaten zu diesem Projekt

Art des ProjektesEU-Projekt koordiniert außerhalb der Universität Münster
Laufzeit an der Universität Münster19.10.2022 - 18.10.2026

Beschreibung

The proposal clearly demonstrates current knowledge base and modern approaches to ASCVD. It deals with a challenging task devoted to the identification of new biomarkers for atherosclerotic cardiovascular prevention. Indeed, it describes possibilities and feasibility for application of relevant achievements of new "-omics" and AI/ML technologies for the identification of new markers as preventive and treatment measures through integrative bio-informative algorithms. Therefore, the proposal is expected to have a significant scientific, technological and socioeconomic impact by creating new knowledge, transfer of knowledge among the COST Action participants and by fostering the career development of early career researchers.

Stichwörtergenetics of multifactorial diseases; next generation sequencing; non-coding RNA; machine learning; genomic data; Atherosclerotic Cardiovascular Diseases; Systems biology; Omics; Machine learning; Personalized medicine
Webseite des Projektshttps://www.cost.eu/search/CA21153
FörderkennzeichenMoU CA21153, Cost-Dol. 067/22
Mittelgeber / Förderformat
  • EU - COST Actions (COST)

Projektleitung der Universität Münster

Stoll, Monika
Humangenetik, Abt. für Genetische Epidemiologie

Antragsteller*innen der Universität Münster

Stoll, Monika
Humangenetik, Abt. für Genetische Epidemiologie

Koordinierende Organisationen außerhalb der Universität Münster

  • Universita Degli Studi Di Milano (UMIL)Italien